Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medplus Health Services has submitted a routine compliance certificate to BSE and NSE under SEBI Regulation 74(5) for the quarter ended December 31, 2025. The certificate was issued by KFIN Technologies, the company's Registrar and Transfer Agent, confirming that details of all securities dematerialized and rematerialized during the quarter have been furnished to the stock exchanges. Separate confirmations were filed for both CDSL and NSDL, the two central depositories in India. The filing is signed by the Company Secretary, Manoj Kumar Srivastava, on January 5, 2026.
This is a standard procedural compliance filing required by SEBI every quarter and has no direct impact on the company's financials, operations, or stock price. Investors can treat it as routine housekeeping with no actionable information.